Profile of Cardiovascular Disease Patients Who are Diagnosed with COPD in a Smoking-Cessation Unit

Juan A Riesco1, María Hidalgo2, David Chipayo3

  • 1Pulmonology Department, CIBER de Enfermedades Respiratorias (CIBERES), University Hospital of Cáceres, Cáceres, Spain. jantonio.riesco@gmail.com.

Advances in Therapy
|June 27, 2020
PubMed

Insights

Four in ten patients with cardiovascular disease (CVD) also have chronic obstructive pulmonary disease (COPD). Smoking cessation units help identify COPD in these patients, with factors like dyspnea and heart failure being significant indicators.

Area of Science:

  • Pulmonology
  • Cardiology
  • Internal Medicine

Background:

  • Cardiovascular diseases (CVD) and chronic obstructive pulmonary disease (COPD) share prevalence and risk factors, often co-occurring in patients.
  • Identifying COPD in CVD patients is crucial for comprehensive management.

Purpose of the Study:

  • To determine the prevalence of COPD among patients with CVD referred to a smoking cessation unit.
  • To analyze the demographic and clinical characteristics of these patients.
  • To identify independent factors associated with COPD in this population.

Main Methods:

  • An observational, prospective study was conducted.
  • 132 patients with smoking habits and CVD were recruited from a smoking cessation unit.
  • Data were collected between October 2015 and March 2017.

Main Results:

  • COPD was diagnosed in 58 patients (43.9%).
  • Significant independent factors associated with COPD included pack-years, reduced forced expiratory volume, chronic heart failure, and modified Medical Research Council (mMRC) dyspnea score.
  • Common CVDs included ischemic heart disease, chronic heart failure, peripheral arterial disease, and atrial fibrillation.

Conclusions:

  • Approximately 40% of CVD patients in smoking cessation units have undiagnosed COPD.
  • Dyspnea, airflow limitation, smoking history, and chronic heart failure are key indicators for COPD in CVD patients.
  • Smoking cessation units serve as valuable settings for COPD diagnosis and management in this cohort.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.1K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.4K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
625